Matches in Wikidata for { <http://www.wikidata.org/entity/Q70156002> ?p ?o ?g. }
Showing items 1 to 51 of
51
with 100 items per page.
- Q70156002 description "article scientifique publié en 1991" @default.
- Q70156002 description "artículu científicu espublizáu en xunu de 1991" @default.
- Q70156002 description "im Juni 1991 veröffentlichter wissenschaftlicher Artikel" @default.
- Q70156002 description "scientific article published on 01 June 1991" @default.
- Q70156002 description "wetenschappelijk artikel" @default.
- Q70156002 description "наукова стаття, опублікована в червні 1991" @default.
- Q70156002 name "Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01" @default.
- Q70156002 name "Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01" @default.
- Q70156002 type Item @default.
- Q70156002 label "Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01" @default.
- Q70156002 label "Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01" @default.
- Q70156002 prefLabel "Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01" @default.
- Q70156002 prefLabel "Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01" @default.
- Q70156002 P1433 Q70156002-96AD549A-9802-43CC-86AC-AD73EF104843 @default.
- Q70156002 P1476 Q70156002-AB255699-5408-4541-961A-287E44D4AB9A @default.
- Q70156002 P2093 Q70156002-29C93C03-348E-413A-928E-0B0FD2CF329E @default.
- Q70156002 P2093 Q70156002-5412FE41-C142-41A3-A0C3-DA77AA3311F5 @default.
- Q70156002 P2093 Q70156002-5A8BC06D-7A9E-4554-8180-5CFC066786B0 @default.
- Q70156002 P2093 Q70156002-738ADB61-0A03-4C9C-8F30-70D474406EBA @default.
- Q70156002 P2093 Q70156002-79CE1F4E-D4CD-4C1C-B27D-DECA8C1E5F16 @default.
- Q70156002 P2093 Q70156002-DFE46E76-A753-452E-9537-E41EBCC425A1 @default.
- Q70156002 P2093 Q70156002-E4A7B3F5-6E3B-4703-A8D5-0ED31254887E @default.
- Q70156002 P304 Q70156002-BEFCEC76-5F5C-43E6-A3E0-B7568EC1FF95 @default.
- Q70156002 P31 Q70156002-AA3575E8-422A-4135-BEAF-4FB577CC0C38 @default.
- Q70156002 P356 Q70156002-D5F8D013-88DB-43F6-A663-C7C8EC186A9E @default.
- Q70156002 P407 Q70156002-D3EA4BCF-FC93-4E8A-9FFE-3357305E9384 @default.
- Q70156002 P433 Q70156002-8BBE04E8-612F-47B2-9307-EF2B2AF38897 @default.
- Q70156002 P478 Q70156002-7E71F420-9B37-4DA9-9809-5B3D493F53B4 @default.
- Q70156002 P577 Q70156002-418A3072-4285-4956-8A8A-BE88DEC671DC @default.
- Q70156002 P698 Q70156002-40D33EF4-9FA3-44D7-AB76-DC05324929E6 @default.
- Q70156002 P921 Q70156002-1C9B0D19-6AF5-46DA-8E82-4D03DEE29934 @default.
- Q70156002 P356 JCO.1991.9.6.918 @default.
- Q70156002 P698 2033428 @default.
- Q70156002 P1433 Q400292 @default.
- Q70156002 P1476 "Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01" @default.
- Q70156002 P2093 "D M Loudenslager" @default.
- Q70156002 P2093 "H M Vriesendorp" @default.
- Q70156002 P2093 "J L Klein" @default.
- Q70156002 P2093 "J M Herpst" @default.
- Q70156002 P2093 "M A Germack" @default.
- Q70156002 P2093 "P K Leichner" @default.
- Q70156002 P2093 "S E Order" @default.
- Q70156002 P304 "918-928" @default.
- Q70156002 P31 Q13442814 @default.
- Q70156002 P356 "10.1200/JCO.1991.9.6.918" @default.
- Q70156002 P407 Q1860 @default.
- Q70156002 P433 "6" @default.
- Q70156002 P478 "9" @default.
- Q70156002 P577 "1991-06-01T00:00:00Z" @default.
- Q70156002 P698 "2033428" @default.
- Q70156002 P921 Q941 @default.